Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
CEO: Theodore L. Harris. Company website
Balchem Corp (BCPC) trades at $167.05, up 0.78% on the day, as of Sep 20, 2026 14:58 UTC.
Balchem Corp has a market capitalisation of $5.37B, calculated from the live BCPC share price and shares outstanding.
BCPC trades at a trailing P/E of 32.88, from earnings per share of $5.08 over the last twelve months.
Balchem Corp generated revenue of $1.09B over the trailing twelve months, which puts the stock at 4.94 times sales.
Yes. Balchem Corp pays a dividend yielding 0.60% on the current share price.
BCPC has traded between $139.17 and $183.90 over the past 52 weeks, and the last price is 9.2% below that high.
Yes. Balchem Corp keeps 15.14% of revenue as net income over the trailing twelve months.
Wall Street analysts rate BCPC Buy, with an average price target of $215.00, 28.7% above the current price.
Balchem Corp is classified under the Basic Materials sector and the Chemicals - Specialty industry, and is domiciled in US.
Theodore L. Harris is the chief executive of Balchem Corp, which employs 1,379 people.
QFI Terminal shows BCPC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open BCPC in Terminal See plans